Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

T helper 2 biasedde novoimmune response to Keyhole Limpet Hemocyanin in humans

(2009) D. Spazierer et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

(2009) Thomas J. Scriba et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis

(2009) H. M. Vordermeier et al.   INFECTION AND IMMUNITY

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa

(2008) Tony Hawkridge et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

(2008) Salim Abdulla et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

(2008) Roger H. Brookes et al.   PLoS One